JPWO2021022008A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021022008A5
JPWO2021022008A5 JP2022506419A JP2022506419A JPWO2021022008A5 JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5 JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022506419 A JP2022506419 A JP 2022506419A JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5
Authority
JP
Japan
Prior art keywords
drawings
present application
invention described
application
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543046A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044196 external-priority patent/WO2021022008A1/en
Publication of JP2022543046A publication Critical patent/JP2022543046A/ja
Publication of JPWO2021022008A5 publication Critical patent/JPWO2021022008A5/ja
Pending legal-status Critical Current

Links

JP2022506419A 2019-07-30 2020-07-30 ウイルス様粒子ワクチン Pending JP2022543046A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962880547P 2019-07-30 2019-07-30
US62/880,547 2019-07-30
US202062990318P 2020-03-16 2020-03-16
US62/990,318 2020-03-16
PCT/US2020/044196 WO2021022008A1 (en) 2019-07-30 2020-07-30 Virus-like particle vaccines

Publications (2)

Publication Number Publication Date
JP2022543046A JP2022543046A (ja) 2022-10-07
JPWO2021022008A5 true JPWO2021022008A5 (lt) 2023-08-07

Family

ID=74228282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506419A Pending JP2022543046A (ja) 2019-07-30 2020-07-30 ウイルス様粒子ワクチン

Country Status (7)

Country Link
US (2) US20220280633A1 (lt)
EP (1) EP4004036A4 (lt)
JP (1) JP2022543046A (lt)
CN (1) CN114729030A (lt)
AU (1) AU2020321021A1 (lt)
CA (1) CA3149390A1 (lt)
WO (1) WO2021022008A1 (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3864163T (pt) 2018-10-09 2024-04-30 Univ British Columbia Composições e sistemas que compreendem vesículas competentes para transfeção isentas de solventes orgânicos e detergentes e métodos relacionados com as mesmas
WO2022008973A2 (en) * 2020-07-10 2022-01-13 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN112760420B (zh) * 2021-02-05 2023-05-26 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN114656529B (zh) * 2021-02-08 2024-05-31 暨南大学 一种新型冠状病毒t细胞的抗原表位肽及其应用
CN114957409A (zh) * 2021-02-26 2022-08-30 中国科学院上海巴斯德研究所 基于s蛋白r815位点的冠状病毒干预的方法和产品
WO2022191742A1 (en) * 2021-03-11 2022-09-15 Dukhovlinov Ilya Vladimirovich A method for assessment of the cellular immune
IL308478A (en) * 2021-05-13 2024-01-01 Benevira Inc Methods and compositions for treating viral infection
WO2022261355A1 (en) * 2021-06-09 2022-12-15 Chimeron Bio Corporation Self-amplifying rna-based vlp vaccines
WO2023023597A1 (en) * 2021-08-18 2023-02-23 Nanored Llc Virus-like particle
AU2022341555A1 (en) * 2021-09-09 2024-01-18 Universität Basel Biologically produced nucleic acid for vaccine production
WO2023062651A1 (en) * 2021-10-13 2023-04-20 Padmanabh Patil Harshad Virus-like particles for respiratory syncytial virus and method of preparation thereof
RU2769224C1 (ru) * 2021-12-30 2022-03-29 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Рекомбинантные вирусоподобные частицы для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003242742B2 (en) * 2002-06-20 2009-04-30 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
JP2010519203A (ja) * 2007-02-16 2010-06-03 メルク・シャープ・エンド・ドーム・コーポレイション 生物活性分子の活性を強化するための組成物及び方法
WO2011002522A2 (en) * 2009-07-02 2011-01-06 Medimmune, Llc Methods of making and using synthetic viruses
JP2013542928A (ja) * 2010-09-30 2013-11-28 フランバックス ソチエタ レスポンサビリタ リミテ ビロソーム粒子の生成
DK2811981T3 (da) * 2012-02-07 2019-06-11 Infectious Disease Res Inst Forbedrede adjuvansformuleringer, der omfatter tlr4-agonister, og fremgangsmåder til anvendelse heraf
US10829543B2 (en) * 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
WO2016039620A2 (en) * 2014-09-12 2016-03-17 Bestewil Holding B.V. Respiratory syncytial virus virosomes
WO2017046801A1 (en) * 2015-09-17 2017-03-23 Ramot At Tel-Aviv University Ltd. Coronaviruses epitope-based vaccines

Similar Documents

Publication Publication Date Title
JP2023115329A5 (lt)
JP2022184985A5 (lt)
JP2021184963A5 (lt)
JP2022068302A5 (lt)
JP2024036694A5 (lt)
JPWO2021188969A5 (lt)
JP2020010717A5 (lt)
JP2019142968A5 (lt)
JP2023022224A5 (lt)
JP2022191211A5 (lt)
JP2023181322A5 (lt)
JP2023166402A5 (lt)
JPWO2021213924A5 (lt)
JP2022024034A5 (lt)
JP2022185040A5 (lt)
JP2022122972A5 (lt)
JP2024012435A5 (lt)
JP2020079331A5 (lt)
JP2021008510A5 (lt)
JP2023085551A5 (lt)
JP2022060220A5 (lt)
JP2023078173A5 (lt)
JP2023145479A5 (lt)
JPWO2021022008A5 (lt)
JPWO2019183186A5 (lt)